Oct 2, 2024 4:05 pm EDT Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company Read More
Oct 1, 2024 7:05 am EDT Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences Read More
Aug 20, 2024 4:05 pm EDT Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting Read More
Jul 18, 2024 4:05 pm EDT Codexis to Report Second Quarter 2024 Financial Results on August 8 Read More
Jul 1, 2024 4:05 pm EDT Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets Read More